Breaking News

Sun Pharma Divests Two U.S. Manufacturing Sites to New CDMO

CRO Frontage Labs creates Frontida Biopharm to provide contract manufacturing and co-development services

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Frontida BioPharm, an affiliate of contract research organization (CRO) Frontage Laboratories, has acquired Sun Pharma’s oral solid dosage manufacturing facilities in Philadelphia, PA, and Aurora, IL, and 15 related pharmaceutical products. Frontida has been founded to provide contract manufacturing and co-development services for Frontage’s large base of pharmaceutical industry clients and partners, and will utilize the facilities as its primary base of operations. In connection with the ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters